Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We advised Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Canada $3.5 billion global bond offering
We advised the underwriters on the investment-grade debt offering
G2D Investments R$260 million IPO
We advised the joint bookrunners on the IPO, São Paulo Stock Exchange and Bermuda Stock Exchange listing
Alphawave IP Group £856 million IPO
We advised the underwriters on the IPO and LSE listing
Equinix $2.6 billion bond offering, including $1 billion in green bonds
We advised Equinix on the SEC-registered notes offering
Fresenius Medical Care $1.5 billion notes offering
We advised the initial purchasers on the Rule 144A / Regulation S notes offering
China Water Affairs Group $200 million high-yield notes offering
We advised the initial purchasers on the Regulation S notes offering
Fluor $600 million convertible preferred stock offering
The company issued Series A cumulative perpetual convertible preferred stock
Hopson Development Holdings $300 million high-yield notes offering
We advised the initial purchasers on the Regulation S notes offering
Clarivate $5.3 billion acquisition of ProQuest
We are advising Clarivate on the acquisition
Charles River Laboratories acquisition of Vigene Biosciences
We are advising Charles River on the acquisition